<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-166938</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Response to the comment by Van den Reek et al. on Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>García-Doval, I</dc:creator>
<dc:creator>Dávila-Seijo, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Actas Dermosifiliogr;108(7): 697-698, sept. 2017.</dc:source>
<dc:identifier>ibc-166938</dc:identifier>
<dc:title xml:lang="es">Respuesta a la réplica de Van den Reek et al. a: El análisis de supervivencia no es un buen método para evaluar la seguridad o la efectividad de los tratamientos sistémicos en psoriasis</dc:title>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d23106^s22062</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30150</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d12002^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>201709</dc:date>
</metadata>
</record>
</ibecs-document>
